Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-001978
Filing Date
2024-01-19
Accepted
2024-01-19 21:02:44
Documents
1
Period of Report
2024-01-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5694
  Complete submission text file 0001209191-24-001978.txt   7337
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
Dissanaike Sharmila (Reporting) CIK: 0001885069 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33221 | Film No.: 24546916